Closed · RFA-FD-15-010 · CFDA 93.103 · Discretionary

IMEDS- Methods Research Agenda

Federal grant opportunity posted by Food and Drug Administration, cataloged on Grants.gov.

$1-$1M
Award range
Closed
Status
June 15, 2015
Close date
1
Expected awards

The verdict

IMEDS- Methods Research Agenda is a closed discretionary listing from Food and Drug Administration that offered $1 -- $1,000,000 across 1 expected award. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 481 other opportunities from Food and Drug Administration.

$1-$1M
award range
Closed
application status
1
expected award
93.103
CFDA program

Archived opportunity record

IMEDS- Methods Research Agenda is closed (last close June 15, 2015). The parent program page for CFDA 93.103 is the reliable place to catch re-announcements. Food and Drug Administration still indexes 481 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed June 15, 2015

Posted Apr 15 Closes Jun 15

Est. Total Funding

$1,000,000

Expected Awards

1

Instrument

Grant

Description

Section 905 of the Food and Drug Administration Amendments Act (FDAAA) mandates FDA to develop an enhanced ability to monitor the safety of drugs after these products reach the market. In response to this mandate, FDA launched its Sentinel Initiative, a long-term program designed to build and implement an electronic system for monitoring the safety of medical products in the post market setting. FDA has already created significant infrastructure on which to operate such a system: through its Mini-Sentinel pilot, a distributed database with access to more than 150 million patient records has been created (the Sentinel Distributed Database). In order to optimally leverage these data, however, new analytic methodologies will be required. IMEDS-Methods is a program within the Reagan-Udall Foundation (RUF) that supports the FDA's scientific mission of serving public health needs by initiating and facilitating research into the methods of safety evaluation in large databases. IMEDS-Methods aims to improve the tools for conducting post-marketing safety surveillance using automated healthcare data and to foster their adoption. Research Objectives IMEDS plans to conduct methods research in five core areas: (1) addressing bias in estimates from observational studies; (2) better understanding uses and limitations of the data; (3) applying lessons learned from earlier IMEDS projects to FDA surveillance activities; (4) expanding the surveillance question to continuous Risk/Benefit assessment; and (5) continuing to support qualified investigators in industry, government, and academic settings by providing access to de-identified electronic healthcare data and computing resources through the IMEDS Research Laboratory.

Catch-all / unrestricted eligibility mark · RFA-FD-15-010

Grants.gov marks IMEDS- Methods Research Agenda with a catch-all / unrestricted eligibility code (Others (see official listing text)). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity codes span Community Development · Education · Environment · Food and Nutrition · Health · Income Security and Social Services · Science and Technology / R&D (CD;ED;ENV;FN;HL;IS;ST). 119 other Food and Drug Administration listings share this eligibility-code string (25% of 482).

Code 25
Others (see official listing text)

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Vieda Hubbard Grants Management Specialist Phone 240-402-7588

What to do next

IMEDS- Methods Research Agenda is closed; use the parent program and agency catalog for the next funding cycle.

  • Parent CFDA 93.103 may publish future NOFOs under the same assistance listing. Open program
  • Food and Drug Administration Research indexes 42 Grants.gov listings in this extract. Program profile
  • Food and Drug Administration lists 481 other indexed opportunities on PlainGrants. Agency catalog

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants